Physician profile
Michael Scarpone
NPI 1740286673
$10,585.86
in general payments reported to CMS, 2019-2025
16 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,025 · 2020: $1,504 · 2021: $3,443 · 2022: $162 · 2023: $56.81 · 2024: $210 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $9,870.38 | 2019-2021 | |
| Amgen INC. | $182.09 | 2022-2024 | Evenity, Enbrel, Tavneos |
| Bioventus LLC | $144.12 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane, Xcell |
| Boston Scientific Corporation | $79.72 | 2025 | Intracept |
| Radius Health, INC. | $64.50 | 2022 | |
| Depuy Synthes Sales INC. | $43.90 | 2022-2025 | Monovisc, Orthovisc |
| Abbvie INC. | $28.77 | 2024 | |
| Hydrocision, INC. | $25.60 | 2024 | Tenjet |
| Abbott Laboratories | $23.07 | 2025 | Octrode |
| Relievant Medsystems, INC. | $22.28 | 2023 | Intracept |
| Vertex Pharmaceuticals Incorporated | $22.13 | 2025 | |
| Sanofi-Aventis U.S. LLC | $17.14 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.85 | 2023 | Zilretta, Exparel, Iovera |
| Si-Bone, INC. | $16.37 | 2020 | |
| Organogenesis INC. | $15.38 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $13.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Scarpone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.